Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 25,134 | 28,599 | 13,520 | 8,675 | 7,853 |
| Operating Income | -25,134 | -28,599 | -13,520 | -8,675 | -7,853 |
| Interest Expense | 0 | 82 | 130 | 127 | 57 |
| Other Income | 166 | 32 | -270 | -180 | 24 |
| Pre-tax Income | -24,968 | -28,649 | -13,920 | -8,982 | -7,886 |
| Net Income Continuous | -24,968 | -28,649 | -13,920 | -8,982 | -7,886 |
| Net Income | $-24,968 | $-28,649 | $-13,920 | $-8,982 | $-7,886 |
| EPS Basic Total Ops | -0.50 | 2.09 | -2.01 | -3.31 | -0.90 |
| EPS Basic Continuous Ops | -0.50 | 2.10 | -2.01 | -3.31 | -0.90 |
| EPS Diluted Total Ops | -0.50 | 2.09 | -2.01 | -3.31 | -0.90 |
| EPS Diluted Continuous Ops | -0.50 | 2.10 | -2.01 | -3.31 | -0.90 |
| EBITDA(a) | $-24,404 | $-28,306 | $-13,358 | $-8,516 | $-7,691 |